| Genotypes | C allele dominance | |||||
---|---|---|---|---|---|---|---|
CC n = 31 | CT n = 69 | TT n = 28 | P | CC + CT n = 100 | TT n = 28 | P | |
Lesions in biopsies | |||||||
 Incisura | |||||||
  yes | 10 (32%) | 30 (43%) | 18 (64%) | 0.04 | 40 (40%) | 18 (64%) | 0.02 |
  no | 21 (68%) | 39 (57%) | 10 (36%) |  | 60 (60%) | 10 (36%) |  |
 Antrum | |||||||
  yes | 28 (90%) | 62 (90%) | 21 (75%) | 0.15 | 90 (90%) | 21 (75%) | 0.06 |
  no | 3 (10%) | 7 (10%) | 7 (25%) |  | 10 (10%) | 7 (25%) |  |
 Corpus | |||||||
  yes | 1 (3%) | 5 (7%) | 5 (18%) | 0.17 | 6 (6%) | 5 (18%) | 0.22 |
  no | 30 (97%) | 64 (93%) | 23 (82%) |  | 94 (94%) | 23 (82%) |  |
Atrophy | |||||||
  Absent/Mild | 19 (61%) | 43 (62%) | 12 (43%) | 0.19 | 62 (62%) | 12 (43%) | 0.07 |
  Moderate/Severe | 12 (39%) | 26 (38%) | 16 (57%) |  | 38 (38%) | 16 (57%) |  |
IM | |||||||
  Absent/Mild | 14 (45%) | 34 (49%) | 6 (21%) | 0.04 | 48 (48%) | 6 (21%) | 0.01 |
  Moderate/Severe | 17 (55%) | 35 (51%) | 22 (79%) |  | 52 (52%) | 22 (79%) |  |
Moderate-to-severe lesions | |||||||
  Absent/Mild | 11 (35%) | 28 (41%) | 4 (14%) | 0.04 | 39 (39%) | 4 (14%) | 0.01 |
  Moderate/Severe | 20 (65%) | 41 (59%) | 24 (86%) |  | 61 (61%) | 24 (86%) |  |
OLGA | |||||||
  I-II | 26 (84%) | 60 (87%) | 17 (61%) | 0.119 | 86 (86%) | 17 (61%) | 0.003 |
  III-IV | 5 (16%) | 9 (13%) | 11 (39%) |  | 14 (17%) | 11 (39%) |  |
OLGIM | |||||||
  I-II | 20 (65%) | 48 (70%) | 13 (46%) | 0.162 | 68 (68%) | 13 (46%) | 0.036 |
  III-IV | 11 (35%) | 21 (30%) | 15 (54%) |  | 32 (32%) | 15 (54%) |  |